Generic praziquantel in South Africa: the necessity for policy change to provide cheap, safe and effcacious schistosomiasis drugs for the poor, rural population

S T BergeFaculty of Medicine, University of Oslo, NorwayCorrespondence[email protected]

N KabatereineVector Control Division, Ministry of Health, Kampala, Uganda

S G GundersenResearch Department, Sorlandet Hospital HF, and Centre for Development Studies, University of Agder, Norway

M TaylorSchool of Family and Public Health Medicine, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, South Africa

J D KvalsvigSchool of Family and Public Health Medicine, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, South Africa

Z Mkhize-KwitshanaNutritional Intervention Research Unit, South African Medical Research Council.

C JinabhaiSchool of Family and Public Health Medicine, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, South Africa

E F KjetlandCentre for Imported and Tropical Diseases, Department of Infectious Diseases, Oslo University Hospital, Norway, and School of Biological Conservation Sciences, University of KwaZulu-Natal

show all

Generic praziquantel in South Africa: the necessity for policy change to provide cheap, safe and effcacious schistosomiasis drugs for the poor, rural population

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Generic praziquantel in South Africa: the necessity for policy change to provide cheap, safe and effcacious schistosomiasis drugs for the poor, rural population

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date